Evaluation of a lymph node proliferation assay for its ability to detect pharmaceuticals with potential to cause immune-mediated drug reactions

Journal of Immunotoxicology

Volumn 2, Issue 1, 2005, Pages 11-20

  Weaver, James L ^a,m   Chapdelaine, Joan M ^b   Descotes, Jacques ^c   Germolec, Dori ^d   Holsapple, Mike ^e,f   House, Robert ^g,h   Lebrec, Herve ⁱ   Meade, Jean ^j   Pieters, Raymond ^k   Hastings, Kenneth L ^a   Dean, Jack H ^l  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^b Calvert Laboratories Inc   (United States)

^c Poison Center and MDS Pharma Services   (France)

^d NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^e DOW CHEMICAL COMPANY   (United States)

^f ILSI HEALTH AND ENVIRONMENTAL SCIENCES INSTITUTE   (United States)

^g 206 Carnegie Center   (United States)

^h DynPort Vaccine Company LLC   (United States)

ⁱ 3M COMPANY   (United States)

^j NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

^k UTRECHT UNIVERSITY   (Netherlands)

^l Sanofi Aventis   (United States)

^m Division of Applied Pharmacology Research   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

7 [2 (2 AMINO 4 THIAZOLYL) 2 [(2 CARBOXY 2 PROPOXY)IMINO]ACETAMIDO] 3 [(1 ALLYLPYRIDINIUM 2 YL)THIOMETHYL] 3 CEPHEM 4 CARBOXYLIC ACID 1 OXIDE BROMIDE; ABACAVIR; ANTIBIOTIC AGENT; CLONIDINE; CM 40420; CM 40954; LAMOTRIGINE; METFORMIN; NEVIRAPINE; OFLOXACIN; PHENOBARBITAL; PROCAINAMIDE; STREPTOZOCIN; SULFAMETHOXAZOLE; UNCLASSIFIED DRUG; ZOMEPIRAC;

ALLERGIC REACTION; ANAPHYLAXIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTHMA; CELL PROLIFERATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG HYPERSENSITIVITY; DRUG INFORMATION; DRUG MONITORING; FACE EDEMA; FEMALE; GLOMERULONEPHRITIS; HEMOLYTIC ANEMIA; HUMAN; HYPERSENSITIVITY REACTION; INJECTION SITE REACTION; LEUKOPENIA; LYMPH NODE; MOUSE; NONHUMAN; PRIMATE; PRIORITY JOURNAL; PRURITUS; RASH; URTICARIA;

ANIMALIA; PRIMATES;

EID: 28244441671     PISSN: 16602854     EISSN: 1547691X     Source Type: Journal    
DOI: 10.1080/15476910590930100     Document Type: Article

References (24)

1. Albers, R., Broeders, A., van der Pijl, A., Seinen, W., and Pieters, R. 1997. The use of reporter antigens in the popliteal lymph node assay to assess immunomodulation by chemicals. Toxicol. Appl. Pharmacol. 143:102-109.
2. Basketter, D. A., Evans, P., Fielder, R. J., Gerberick, G. F., Dearman, R. J., and Kimber, I. 2002. Local lymph node assay-validation, conduct and use in practice. Food Chem. Toxicol. 40:593-598.
3. Choquet-Kastylevsky, G., Ducluzeau, M., Tedone, R., Nicolas, J., and Descotes, J. 2000. Increased production of interferon-gamma but not IL-4 mRNA by streptozotocin in the popliteal lymph node assay. J. Appl. Toxicol. 20:175-178.
4. Choquet-Kastylevsky, G., Santolaria, N., Tedone, R., Aujoulat, M., and Descotes, J. 2001. Induction of delayed-type hypersensitivity to sulfamethoxazole in mice: Role of metabolites. Toxicol. Lett. 119:183-192.
5. Corre, K. A., and Spielber, T. E. 1988. Adverse drug reaction processing in the United States and its dependence on physician reporting: Zomepirac (Zomax) as a case in point. Ann. Emerg. Med. 17:145-149.
6. Dean, J. H., Twerdok, L. E., Tice, R. R., Sailstad, D. M., Hattan, D. G., and Stokes, W. S. 2001. ICCVAM evaluation of the murine local lymph node assay, II. Conclusions and recommedations of an independent scientific peer review panel. Reg. Toxicol. Pharmacol. 34:256-273.
7. DiMasi, J. A. 2001. Risks in new drug development: Approval success rates for investigational drugs. Clin. Pharmacol. Ther. 69:297-307.
8. Gutting, B. W., Updyke, L. W., and Amacher, D. E. 2002. Investigating the TNP-OVA and direct popliteal lymph node assays for the detection of immunostimulation by drugs associated with anaphylaxis in humans. J. Appl. Toxicol. 22:177-183.
9. Kammuller, M. E., Thomas, C., De Bakker, J. M., Bloksma, N., and Seinen, W. 1989. The popliteal lymph node assay in mice to screen for the immune disregulating potential of chemicals-A preliminary study. Int. J. Immunopharmacol. 11:293-300.
10. Katsutani, N., and Shionoya, H. 1992. Popliteal lymph node enlargement induced by procainamide. Int. J. Immunopharmacol. 14:681-686.
11. Klecak, G. 1985. The Freund's complete adjuvant test and the open epicutaneous test. A complementary test procedure for realistic assessment of allergenic potential. Curr. Prob. Dermatol. 14:152-171.
12. Klecak, G., Geleick, H., and Frey, J. R. 1977. Screening of fragrance materials for allergenicity in the guinea pig I. Comparison of four testing methods. J. Soc. Cosmet. Chem. 28:53-64.
13. Krzystyniak, K., Brouland, J. P., Panaye, G., Patriarca, C., Verdier, F., Descotes, J., and Revilard, J. P. 1992. Activation of CD4+ and CD8+ lymphocyte subsets by streptozotocin in murine popliteal lymph node (PLN) test. J. Autoimmun. 5:183-197.
14. Kubicka-Muranyi, M., Goebels, R., Goebel, C., Uetrecht, J., and Gleichmann, E. 1993. T lymphocytes ignore procainamide, but respond to its reactive metabolites in peritoneal cells: Demonstration by the adoptive transfer popliteal lymph node assay. Toxicol. Appl. Pharmacol. 122:88-94.
15. Lerch, M., and Pichler, W. J. 2004. The immunological spectrum of delayed drug-induced exanthems. Curr. Opin. Allergy Clin. Immunol. 4:411-419.
16. Litt, J. Z. 2002. Drug Eruption Reference Manual, 8th Edition. Parthenon Publishing, New York.
17. Loveless, S. E., Ladies, G. S., Gerberick, G. F., Ryan, C. A., Basketter, D. A., Scholes, E. W., House, R. V., Hilton, J., Dearman, R. J., and Kimber, I. 1996. Further evaluation of the local lymph node assay in the final phase of an international collaborative trial. Toxicology 108:141-152.
18. Maurer, T. 1996. Predictive testing for skin allergy. In Allergic Hypersensitivities Induced Chemically (J. G. Vos, M. Younes, and E. Smith, Eds.), pp. 237-259, CRC Press, Boca Raton, FL.
19. Nierkens, S., Nieuwenhuijsen, L., Thomas, M., and Pieters, R. 2004. Evaluation of the use of reporter antigens in an auricular lymph node assay to assess the immunosensitizing potential of drugs. Toxicol. Sci. 79:90-97.
20. Olson, H., Betton, G., Robinson, D., Thomas, K., Monro, A., Kolaja, G., Lilly, P., Sanders, J., Sipes, G., Bracken, W., Dorato, M., Van Deun, K., Smith, P., Berger, B., and Heller, A. 2000. Concordance of the toxicity of pharmaceuticals in humans and in animals. Reg. Toxicol. Pharmacol. 32:56-67.
21. Patriarca, C., Verdier, F., Brouland, J. P., and Descotes, J. 1993. Popliteal lymph node response to procainamide and isoniazid. Role of β-napthoflavone, phenobarbitone, and S9-mix pretreatment. Toxicol. Lett. 66:21-28.
22. Speirs, C. J. 1988. Comparison of the safety of several nonsteroidal anti-inflammatory drugs currently or formerly marketed in the United Kingdom. J. Clin. Pharmacol. 28:88-12.
23. Strom, B. L., Carson, J. L., Morse, M. L., West, S. L., and Soper, K. A. 1987. The effect of indication on hypersensitivity reactions associated with zomepirac sodium and other nonsteroidal anti-inflammatory drugs. Arthritis Rheum. 30:1142-1148.
24. Weaver, J. L., Staten, D., Swann, J., Armstrong, G., Bates, M., and Hastings, K. L. 2003. Detection of systemic hypersensitivity to drugs using standard guinea pig assays. Toxicology 193:203-217.